跳至主要内容
临床试验/NCT06612450
NCT06612450已完成不适用

Turbinate Volume Reduction Under Local Anesthesia: Randomized Clinical Trial; Our Experience

Kafrelsheikh University2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2022年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
90
试验地点
2
主要终点
NOSE score

研究概览

简要总结

The purpose of this trial is to know which method is better in delivering radiofrequency waves for hypertrophied turbinates: coblation or RavoR technique? Researchers will compare both techniques in randomized blinded manner patients will have subjective outcomes like NOSE score, pain Objective outcomes like Turbinate size over long term clinical follow up visits for 1 year

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

only one surgeon did the surgeries, other two assessors didnt know which intervention was done, the patient didn't know which group did they belong to

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • All patients with the following criteria were eligible for inclusion:
  • Age group: 18-60 years old.
  • Patients complaining of chronic nasal obstruction because of bilateral (HIT) diagnosed by our former protocol refractory to medical treatment for at least three months.
  • Evident (HIT) on the CT nose and paranasal sinuses with mainly soft tissue component hypertrophy with or without minimal septal deviation without any other cause for the obstruction.
  • Patients who are unfit for general anesthesia

排除标准

  • All Patients with:
  • Marked septal deviation or Concha Bullosa, Nasal polyps, Sinonasal Tumors, Any previous nasal surgeries or radiotherapy, Chronic sinusitis or Cystic Fibrosis, Pregnancy, Patients with severe bleeding tendency, coagulopathy disorder, and Patients who refuse participation in this study were excluded from our study

结局指标

主要结局

NOSE score

时间窗: 1 year

nasal obstruction symptom score for subjective analysis of patient symptom before and after intervention

Pain VAS score

时间窗: 1-3 months postoperative

patient score on a scale from 0 to 10 where 0 is no pain and 10 is most severe pain

Turbinate Size grading

时间窗: 1 year postoperative

endoscopic grading of turbinate size before and after intervention from 0-4 where 1 is 25% of nasal cavity

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ibrahim M. Gehad

Dr. Ibrahim Gehad

Kafrelsheikh University

研究点 (2)

Loading locations...

相似试验